{{Rsnum
|rsid=10403955
|Gene=CYP2B6
|Chromosome=19
|position=41003533
|Orientation=plus
|GMAF=0.2778
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CYP2B6
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 4.7 | 42.2 | 53.1
| HCB | 2.2 | 26.7 | 71.1
| JPT | 9.1 | 34.1 | 56.8
| YRI | 11.3 | 46.8 | 41.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 26.7 | 71.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20639527
|Title=Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort
|OA=1
}}

{{PMID Auto
|PMID=21694616
|Title=CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.
}}

{{on chip | HumanOmni1Quad}}